reference/34676551

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34676551

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1471-2407
issueIdentifier	1
pageRange	1116-
publicationName	BMC Cancer
startingPage	1116
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1a896d333c62274ea8c31cf21a4e320d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8b3cc2bcd4fff5076dd998b7fc70ea3d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ac708a383ea953f3906d22841a99139b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fb7b1dfdc412743559d246c17b8240c7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_010067ca867e8707954f072032ffb367 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_27cd6c065fbf945225a5385d2809facf http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_38ee31e882d31dabd40efd68418c1336
bibliographicCitation	Gu P, Ling B, Ma W, Zhang J, Zhang W, Zeng Y, Liu Y, Chi J, Ruan X, Zheng X, Wei S, Gao M. Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects. BMC Cancer. 2022 Nov 01;22(1):1116. PMID: 36319978; PMCID: PMC9624013.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fd6233941098fb82e04f9fc2ea58625 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3648784c6f26e313dd99fd7e07a9f29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8449f9c9b7d8d4d694875d7e28cfc028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05aacb005fa44ab7f0954f19595061bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73ab1b7525c19276b152bccd610f9365 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07402d39ff9f59e2df00fe9dff5b4cac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37bb1c629b8f831c1763305b4cf27aa0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fcadd604c8eb41e14c2d583073275fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_994f7e7c790e793bc8729864d6a930a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d42059ea0c097efdca91edbc9f59fab3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4332f163bc8f61d6c822977a3bced69b
date	2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s12885-022-10173-7 https://pubmed.ncbi.nlm.nih.gov/PMC9624013 https://pubmed.ncbi.nlm.nih.gov/36319978
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
discusses	http://id.nlm.nih.gov/mesh/M0475654 http://id.nlm.nih.gov/mesh/C536914
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID1544 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d005b09de8389ea76852d6ed46a56b23 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122074

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID169355

Total number of triples: 50.